NASDAQ · Biotechnology

ABVC BioPharma, Inc. (ABVC) Stock

$1.00 +2.04% NASDAQ: ABVC Healthcare

Valuation

MetricValue
Price$1.00
Market Cap$26.00M
P/E Ratio-3.42
P/B Ratio2.56
P/S Ratio-32.99
EPS (TTM)$-0.39
52-Week High$3.40
52-Week Low$0.71
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-71.47%
ROA-40.73%
ROCE-53.34%
Gross Margin0.00%
Operating Margin0.00%
Net Margin992.85%
Debt/Equity0.17
Current Ratio0.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$0$1.0M$0
Operating Profit$-12.0M$-15.0M$-7.0M$-5.0M$-7.0M
Net Profit$-13.0M$-16.0M$-8.0M$-5.0M$-8.0M
EPS$-5.10$-5.20$-1.80$-0.42$-0.39
Op Margin-3290.1%-1558.5%-4439.2%-923.3%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$11.0M$8.0M$8.0M$21.0M
Total Liabilities$5.0M$6.0M$7.0M$7.0M$8.0M
Cash$6.0M$1.0M$1.0M$1.0M$1.0M
Borrowings$3.0M$3.0M$3.0M$3.0M$3.0M

Latest News

ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders NewMediaWire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-7.0M$-4.0M$-2.0M$-3.0M
Investing Cash Flow$-1.0M$-2.0M$0$0$-1.0M
Financing Cash Flow$-1.0M$0$3.0M$2.0M$0
Net Cash Flow$2.0M$-5.0M$-1.0M$0$0
Free Cash Flow$-8.0M$-8.0M$-4.0M$-2.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-3.58
FCF Yield-9.32%
Quick Ratio0.07
Interest Coverage-47.11
Return 1Y-64.15%
Return 3Y-69.52%
Return 5Y-97.44%

Ownership

Insiders Held18.57%
Institutions Held3.14%
Institutions Float Held3.86%
Institutional HolderSharesReport Date
Geode Capital Management, LLC221,1692026-03-31
Vanguard Capital Management LLC190,5742026-03-31
Vanguard Fiduciary Trust Co97,3632026-03-31
Renaissance Technologies, LLC95,1002026-03-31
State Street Corporation72,8002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About ABVC BioPharma, Inc.

ABVC BioPharma, Inc. is led by CEO Uttam Yashwant Patil, employs 16 people, headquartered in US, publicly traded since 2004.

ABVC BioPharma, Inc. (ABVC) stock trades at $1.00 with a market capitalization of $26.00M. The stock is valued at a price-to-earnings (P/E) ratio of -3.42, price-to-book of 2.56, price-to-sales of -32.99. Over the past 52 weeks the stock has ranged between $0.71 and $3.40, and currently trades 70.6% below its 52-week high.

On profitability, ABVC BioPharma, Inc. generates a return on equity (ROE) of -71.47%, return on capital employed of -53.34%, an operating margin of 0.00%, a net profit margin of 992.85%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides